title: Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
abstract: Helper-dependent adenovirus (HD-Ad) vectors with all adenoviral genes deleted mediate very long-term expression of therapeutic transgenes in a variety of animal models of disease. These vectors are associated with reduced toxicity and improved safety relative to traditional early region 1 deletion first-generation Ad (FG-Ad) vectors. Many studies have clearly demonstrated that FG-Ad vectors induce innate and adaptive immune responses in vivo; however, a comprehensive analysis of host immune responses to HD-Ad vectors has not yet been performed. In DBA/2 mice, intravenous injection of HD-Ad vectors encoding LacZ (HD-AdLacZ) or a murine secreted alkaline phosphatase (HD-AdSEAP) induced an early expression of inflammatory cytokine and chemokine genes in the liver, including interferon-inducible protein 10, macrophage inflammatory protein 2, and tumor necrosis factor alpha, and were expressed in a pattern similar to that induced by FG-Ad vectors encoding AdSEAP. Like AdSEAP, and consistent with the pattern of cellular gene expression, HD-AdLacZ and HD-AdSEAP induced the recruitment of CD11b-positive leukocytes to the transduced liver within hours of administration. AdSEAP also induced a second phase of liver inflammation, consisting of inflammatory gene expression and CD3-positive lymphocytic infiltrates 7 days posttransduction. In contrast, beyond 24 h no infiltrates or expression of inflammatory genes was detected in the livers of mice receiving HD-AdSEAP. Despite the lack of liver inflammation at 7 days, Ad-specific cytotoxic T lymphocytes could be detected in mice receiving HD-AdSEAP. This lack of liver inflammation was not due to reduced transduction since levels of transgene expression and the amounts of vector DNA in the liver were equivalent in mice receiving HD-AdSEAP and AdSEAP. These results demonstrate that HD-Ad vectors induce intact innate but attenuated adaptive immune responses in vivo.
authors.affiliation: Faculty of Medicine, University of Calgary, 3330 Hospital Dr. N.W., Calgary, AB, T2N 4N1 Canada. dmuruve@ucalgary.ca
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Muruve
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Cotter
authors.forename: Anne K
authors.initials: AK
authors.lastname: Zaiss
authors.forename: Lindsay R
authors.initials: LR
authors.lastname: White
authors.forename: Qiang
authors.initials: Q
authors.lastname: Liu
authors.forename: Trevor
authors.initials: T
authors.lastname: Chan
authors.forename: Sharon A
authors.initials: SA
authors.lastname: Clark
authors.forename: P Joel
authors.initials: PJ
authors.lastname: Ross
authors.forename: Robert A
authors.initials: RA
authors.lastname: Meulenbroek
authors.forename: Gunhild M
authors.initials: GM
authors.lastname: Maelandsmo
authors.forename: Robin J
authors.initials: RJ
authors.lastname: Parks
mesh_terms: D000256:Adenoviridae / Q000276:immunology*; D000818:Animals; D003673:Defective Viruses / Q000276:immunology*; D005822:Genetic Vectors / Q000276:immunology*; D007113:Immunity, Innate; D051379:Mice; D008811:Mice, Inbred DBA; D014161:Transduction, Genetic; D019076:Transgenes